Skip to main content
Equibles

UBS Group AG

Position in RPRX — Royalty Pharma plc

CIK 1610520 ZURICH, V8
Back to RPRX Full portfolio

Position in RPRX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$176,247,464
+$89,316,088 QoQ
Shares Held
3,143,347
+73.5% QoQ
Ownership
0.547%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#23
of 646 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in RPRX Over Time

Shares Held

Position Value (USD)

Derivatives in RPRX

reported options exposure · as of Sep 30, 2025
CallValue
$2,116,800
CallShares
60,000
PutValue
$1,157,184
PutShares
32,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. RPRX ranks #12 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in RPRX

Export CSV
34 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $176,247,464 3,143,347
2026-03-31 $86,931,376 1,812,203
2025-12-31 $77,505,307 2,005,831
2025-09-30 $54,387,575 1,541,598
2025-09-30 $2,116,800 60,000
2025-09-30 $1,157,184 32,800
2025-06-30 $79,509,741 2,206,765
2025-06-30 $1,181,784 32,800
2025-06-30 $2,161,800 60,000
2025-03-31 $1,867,800 60,000
2025-03-31 $1,021,064 32,800
2025-03-31 $42,102,575 1,352,476
2024-12-31 $1,275,500 50,000
2024-12-31 $43,507,865 1,705,522
2024-09-30 $45,758,648 1,617,485
2024-06-30 $33,888,611 1,285,120
2024-03-31 $21,257,023 699,935
2023-12-31 $24,353,889 866,995
2023-09-30 $20,204,100 744,440
2023-06-30 $21,202,698 689,743
2023-06-30 $1,844,400 60,000
2023-03-31 $18,085,437 501,955
2022-12-31 $29,054,507 735,185
2022-09-30 $19,762,972 491,861
2022-06-30 $8,315,469 197,799
2022-03-31 $18,610,761 477,689
2021-12-31 $17,976,732 451,110
2021-09-30 $10,521,797 291,140
2021-06-30 $6,148,500 150,000
2021-06-30 $27,444,607 669,544
2021-03-31 $19,390,527 444,533
2020-12-31 $11,165,452 223,086
2020-09-30 $2,252,848 53,550
2020-06-30 $432,143 8,901